Indication
Anti-MAG Neuropathy
1 clinical trial
3 products
Clinical trial
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders:Status: Recruiting, Estimated PCD: 2025-12-01
Product
RituximabProduct
PlaceboProduct
Premedications